Here's Why AbbVie Is a Great Healthcare Stock for Long-Term Investors

Pharmaceutical giant AbbVie (NYSE: ABBV) is best known for its mega-blockbuster drug Humira, which raked in more revenue than any other medicine in the world in yet another year of successive growth in 2020. In this segment of Backstage Pass, recorded on Sept. 20, 2021, Fool contributors Brian Withers and Rachel Warren discuss what makes AbbVie such a stalwart choice for the long-term investor's portfolio. 

 

Continue reading

Source Fool.com